Delivery Order SPE2DB20D1004-SPE2DB24FF6H7
Award Date
3/18/24
Potential Completion Date
3/19/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The $2,724.68 firm fixed-price contract has a completion date of March 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a $14,134.77 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The order has an ultimate completion date of December 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,164.73 and an ultimate completion date of March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a specialty medication. The award has a ceiling value of $4,112.90 and a performance period ending on March 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $19,703.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a medical product, to support federal healthcare programs. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a $16,095.56 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract has a period of performance through December 20, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) awarded a $10,669.74 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a $1,697.81 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract provides for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to support federal government medical requirements. The contract has a period of performance through May 8, 2024 and was not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The award has a ceiling value of $7,121.03 and a period of performance through August 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medical supplies to support various military treatment...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,083.44 firm fixed-price delivery order is for the pharmaceutical product "YUPELRI 175 MCG/3 ML SOLUTION UD 3ML". The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...